ASX - Delayed Quote AUD

Adherium Limited (ADR.AX)

Compare
0.0090
-0.0010
(-10.00%)
At close: April 4 at 10:49:42 AM GMT+11
Loading Chart for ADR.AX
  • Previous Close 0.0100
  • Open 0.0100
  • Bid 0.0090 x --
  • Ask 0.0100 x --
  • Day's Range 0.0090 - 0.0100
  • 52 Week Range 0.0090 - 0.0930
  • Volume 77,143
  • Avg. Volume 919,294
  • Market Cap (intraday) 3.001M
  • Beta (5Y Monthly) 2.21
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.08

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution. The company was founded in 2001 and is based in Melbourne, Australia.

www.adherium.com

--

Full Time Employees

June 30

Fiscal Year Ends

--

Sector

--

Industry

Recent News: ADR.AX

View More

Performance Overview: ADR.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

ADR.AX
35.71%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

ADR.AX
78.05%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

ADR.AX
94.55%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

ADR.AX
97.50%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: ADR.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ADR.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    6.83M

  • Enterprise Value

    7.19M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.40

  • Price/Book (mrq)

    4.83

  • Enterprise Value/Revenue

    7.46

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -118.34%

  • Return on Equity (ttm)

    -375.15%

  • Revenue (ttm)

    964.13k

  • Net Income Avi to Common (ttm)

    -11.33M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    387.21k

  • Total Debt/Equity (mrq)

    53.25%

  • Levered Free Cash Flow (ttm)

    -6.93M

Research Analysis: ADR.AX

View More

Company Insights: ADR.AX

Research Reports: ADR.AX

View More

People Also Watch